No Pharma Money We do not accept funding from organizations that profit from the development or distribution of prescription drugs.

David Mitchell embraced by President Biden at the White House

News & Reports

The latest from P4ADNow

The latest news, research, policy analysis, and updates from the fight to lower prescription drug prices.

Latest
Explainers
For Press

News Nov 13, 2026

The Week in Review in Prescription Drug Pricing: P4AD CEO to Testify at Senate Judiciary Hearing, ETHIC Momentum Grows, and more

Our CEO Merith Basey will testify at Tuesday’s Senate Judiciary Committee hearing, “Prescribing Sunshine: How Competition & Transparency Lowers Prescription Drug Costs.” The hearing will focus on legislation to address the pharmaceutical industry’s abuse of the patent system — including through patent thickets, pay-for-delay deals, product hopping, and abuse of the citizen petition process.

Read The Full Story

Stay Up To Date

News and reports from P4ADNow

News Jun 26, 2025

This Week in Drug Pricing: Investors- and Lawmakers – Aren’t Buying Pharma’s “Warnings”, Pharma Front Groups Working Overtime For Big Drug Companies, and P4AD Patient Advocate Speaks Up in New Op-Ed

New reporting from POLITICO reveals that lawmakers from both parties have been snapping up stocks in the 13 largest U.S. pharma companies in recent weeks — all while the drug industry ramps up its…

Read Article News Jun 20, 2025

This Week in Drug Pricing: Patient Victory: ORPHAN Cures Act Excluded from Reconciliation Text, I-MAK Releases New Report on Pharma Patent Abuse, and ICYMI

This week, patients scored a key victory as the Senate Finance Committee released reconciliation text that excluded the harmful ORPHAN Cures Act – a pharma-backed proposal that would have weakened…

Read Article Press Releases Jun 16, 2025

STATEMENT: Senate Drops ORPHAN Cures Act from Reconciliation Package Following Strong Patient Opposition

Patients For Affordable Drugs Now is applauding a patient-driven victory as the harmful ORPHAN Cures Act was excluded from the reconciliation text released by the Senate Finance Committee today …

Read Article News Jun 13, 2025

This Week in Drug Pricing: P4ADNOW and AARP Send Letter on OPRHAN Cures to Senate, Most Favored Nation: One Month Out, Spotlight on Cell and Gene Therapies, and ICYMI

To safeguard hard-fought and cost-saving drug price reforms, P4ADNow and AARP sent a joint letter to all Senators to oppose the inclusion of the ORPHAN Cures Act in the reconciliation bill.

Read Article News Jun 6, 2025

This Week in Drug Pricing: Fighting ORPHAN Cures in the Senate, The Tide Continues to Turn Against PBMs, Supporting Transparency in Drug Advertisements on Capitol Hill, and ICYMI

As the Senate considers the House-passed reconciliation package, P4ADNow is urging lawmakers to reject the inclusion of the ORPHAN Cures Act — an unnecessary Pharma handout that would weaken the…

Read Article News May 30, 2025

This Week in Drug Pricing: Expanding Medicare Negotiation with the SMART Prices Act, Trump’s “Most Favored Nation” Proposal Keeps Moving, and RFK Jr. vs. Big Pharma’s TV Ads

The Strengthening Medicare and Reducing Taxpayer (SMART) Prices Act has been re-introduced by Senators Amy Klobuchar (D-MN) and Peter Welch (D-VT) — legislation that will expand Medicare price…

Read Article News May 23, 2025

This Week in Drug Pricing: P4AD Report Exposes Pharma-Funded Groups Doing the Industry’s Bidding, Centering Patient Stories at CHCI, and The ORPHAN Cures Act Will Cost Taxpayers Billions

As the fight to lower drug prices heats up on Capitol Hill, P4AD released a new report, The Rampant Reach of Pharma’s Hidden Hand, uncovering the pharmaceutical industry’s efforts to fund, influence…

Read Article Press Releases May 22, 2025

STATEMENT: House Conceals Pharma-Backed Loophole in Reconciliation Package, Undermining Popular Progress On Drug Pricing

Today, the House passed a reconciliation package that includes the ORPHAN Cures Act (H.R. 946), a pharma-backed provision that would create new loopholes in the Medicare Drug Price Negotiation…

Read Article News May 16, 2025

This Week in Drug Pricing: Trump Revives Global Drug Pricing Debate, Another Win for Patients and Another Warning For Big Pharma In Court, The ORPHAN Cures Act Would Undermine Patient Savings, Endorsing the No Handouts for Drug Advertisements Act, and ICYMI

This week, President Trump issued an Executive Order (EO) focused on addressing the high cost of prescription drugs.

Read Article Press Releases May 14, 2025

STATEMENT: Patients For Affordable Drugs Now Warns ORPHAN Cures Act Would Undermine Patient Savings

Today, the House Energy and Commerce Committee advanced the ORPHAN Cures Act (H.R. 946) through their markup.

Read Article

Explainers

Drug Pricing Explained

Videos breaking down the policies, practices, and decisions that shape what Americans pay for prescription drugs.

Patient advocate featured in The ETHIC Act Explained

The ETHIC Act Explained: What It Means for Patients

1:49 · Watch on YouTube

How Big Pharma Games the Patent System

3:50 · Watch on YouTube

Dr. Ramachandran discusses delays to Medicare drug price negotiation

Congress Delays Negotiation. Patients Pay the Price.

0:51 · Watch on YouTube

Help us spread the word

Subscribe To Our YouTube

For Press

Patients are available for interviews

Looking for a patient perspective or expert comment? We can connect you with patients, policy experts, and the latest research on prescription drug pricing.

[email protected]

Stay Connected

Stay informed about the latest campaigns, policy developments, and ways to help lower prescription drug prices.